Physician profile
Lynne Hung
NPI 1326004748
$8,092.73
in general payments reported to CMS, 2019-2025
31 companies · $1,196 in 2025
The $1,196 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,412 · 2020: $577 · 2021: $492 · 2022: $766 · 2023: $1,000 · 2024: $1,650 · 2025: $1,196.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,845.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,845.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biosense Webster, INC. | $1,836.76 | 2019-2025 | Carto 3, Octaray Mapping Catheter, Soundstar |
| Boston Scientific Corporation | $1,464.17 | 2019-2025 | General - Therapies, Lux-Dx Insertable Cardiac Monitor, Farapulse |
| Janssen Pharmaceuticals, INC | $613.26 | 2019-2024 | Xarelto |
| Abbott Laboratories | $587.33 | 2019-2025 | Ensite, Gallant, Assurity |
| Cardiva Medical, INC. | $585.69 | 2021-2025 | Cardiva Vascade Mvp Vvcs 6-12f, Cardiva Vascade Mvp Xl Vvcs 10-12f |
| Biotronik INC. | $493.44 | 2019-2025 | Biomonitor |
| E.R. Squibb & Sons, L.L.C. | $443.65 | 2019-2025 | Eliquis |
| Pfizer INC. | $439.86 | 2019-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $252.77 | 2019-2025 | Lifevest |
| Sanofi-Aventis U.S. LLC | $241.57 | 2019-2024 | |
| Medtronic, INC. | $203.44 | 2021-2025 | Harmony, Affera Mapping System, Na |
| Cvrx, INC. | $195.96 | 2025 | Barostim Neo System |
| Cook Medical LLC | $123.84 | 2019 | |
| Otsuka America Pharmaceutical, INC. | $70.91 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $60.89 | 2020-2022 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alnylam Pharmaceuticals INC. | $59.85 | 2022-2024 | Amvuttra |
| Amgen INC. | $53.84 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $52.88 | 2019 | |
| Teleflex LLC | $51.45 | 2023 | Guardian, Vascband |
| Chiesi USA, INC. | $45.70 | 2024-2025 | Kengreal |
| Edwards Lifesciences Corporation | $35.77 | 2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Lundbeck LLC | $34.14 | 2019 | |
| Cordis US Corp. | $24.50 | 2024 | Mynx Control |
| Novartis Pharmaceuticals Corporation | $23.85 | 2020 | |
| Medline Industries Lp | $16.79 | 2024 | |
| Irhythm Technologies, INC. | $15.70 | 2020 | |
| Baxter Healthcare | $14.26 | 2023 | Hillrom - Carnation Ambulatory Monitor |
| Kestra Medical Technology Services, INC. | $13.46 | 2023 | Assure Wcd |
| Kiniksa Pharmaceuticals International, Plc | $13.37 | 2024 | Arcalyst |
| Impulse Dynamics (USA) INC. | $12.35 | 2022 | |
| Altathera Pharmaceuticals LLC | $11.28 | 2024 | Sotalol Hydrochloride |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lynne Hung listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.